Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:FTSV

Forty Seven (FTSV) Stock Price, News & Analysis

Forty Seven logo

About Forty Seven Stock (NASDAQ:FTSV)

Advanced Chart

Key Stats

Today's Range
$95.51
$95.51
50-Day Range
$95.51
$95.51
52-Week Range
$5.53
$95.51
Volume
N/A
Average Volume
1.61 million shs
Market Capitalization
$4.60 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive FTSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forty Seven and its competitors with MarketBeat's FREE daily newsletter.

FTSV Stock News Headlines

Janus Henderson Forty D
Tax Drain Deadline: Protect Your Wealth Before September 15th
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Janus Henderson Forty T
Janus Henderson Forty S
See More Headlines

FTSV Stock Analysis - Frequently Asked Questions

Forty Seven Inc (NASDAQ:FTSV) issued its earnings results on Tuesday, November, 12th. The company reported ($0.38) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.38). The company earned $15.68 million during the quarter, compared to analyst estimates of $15.80 million.

Forty Seven (FTSV) raised $100 million in an initial public offering on Thursday, June 28th 2018. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. Morgan Stanley and Credit Suisse served as the underwriters for the IPO and Canaccord Genuity, BTIG and Oppenheimer were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Forty Seven investors own include Gilead Sciences (GILD), TG Therapeutics (TGTX), Clovis Oncology (CLVS), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Abbott Laboratories (ABT) and ACADIA Pharmaceuticals (ACAD).

Company Calendar

Last Earnings
11/12/2019
Today
8/25/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:FTSV
CIK
N/A
Fax
N/A
Employees
57
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($2.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$87.62 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-50.38%
Return on Assets
-44.35%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.81
Quick Ratio
14.81

Sales & Book Value

Annual Sales
$15.68 million
Price / Sales
293.33
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$7.52 per share
Price / Book
12.70

Miscellaneous

Outstanding Shares
48,156,000
Free Float
N/A
Market Cap
$4.60 billion
Optionable
Not Optionable
Beta
0.40
The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NASDAQ:FTSV) was last updated on 8/26/2025 by MarketBeat.com Staff
From Our Partners